Premium
FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs
Author(s) -
Nambiar Sumathi,
Walinsky Sarah,
Schumann Katherine
Publication year - 2021
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.2175
Subject(s) - food and drug administration , drug , medicine , population , antifungal , administration (probate law) , pharmacology , environmental health , political science , law , dermatology